Home Cart 0 Sign in  

[ CAS No. 62871-28-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 62871-28-7
Chemical Structure| 62871-28-7
Structure of 62871-28-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 62871-28-7 ]

Related Doc. of [ 62871-28-7 ]

Alternatived Products of [ 62871-28-7 ]

Product Details of [ 62871-28-7 ]

CAS No. :62871-28-7 MDL No. :MFCD00795713
Formula : C13H9BrN2O Boiling Point : -
Linear Structure Formula :- InChI Key :DHGHFCLCUPPGKW-UHFFFAOYSA-N
M.W : 289.13 Pubchem ID :4450897
Synonyms :

Calculated chemistry of [ 62871-28-7 ]

Physicochemical Properties

Num. heavy atoms : 17
Num. arom. heavy atoms : 15
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 2.0
Molar Refractivity : 71.25
TPSA : 48.91 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : Yes
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -5.52 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.97
Log Po/w (XLOGP3) : 3.58
Log Po/w (WLOGP) : 3.7
Log Po/w (MLOGP) : 2.86
Log Po/w (SILICOS-IT) : 3.72
Consensus Log Po/w : 3.16

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -4.47
Solubility : 0.00969 mg/ml ; 0.0000335 mol/l
Class : Moderately soluble
Log S (Ali) : -4.29
Solubility : 0.0147 mg/ml ; 0.0000509 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -5.7
Solubility : 0.000578 mg/ml ; 0.000002 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.92

Safety of [ 62871-28-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338-P310 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 62871-28-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 62871-28-7 ]
  • Downstream synthetic route of [ 62871-28-7 ]

[ 62871-28-7 ] Synthesis Path-Upstream   1~9

  • 1
  • [ 95-54-5 ]
  • [ 1761-61-1 ]
  • [ 62871-28-7 ]
YieldReaction ConditionsOperation in experiment
89% With A-FGO catalyst In tetrahydrofuran for 2 h; Reflux; Ionic liquid; Green chemistry General procedure: A mixture of 1,2-phenylenediamine (0.54 g, 5.0 mmol) and 4-nitrobenzaldehyde(1.133 g, 7.5 mmol) in tetrahydrofuran (10 mL) was taken and A-FGO as thecatalyst (0.1 g) was added at room temperature. The resulting mixture was stirredfor 2 h at reflux temperature. Upon completion of the reaction (monitored by TLC), dichloromethane (10 mL) was added while being stirred for 15 min at ambient temperatures. The catalyst was removed by filtration and washed with dichloromethane for reuse in the next cycles (up to five runs) (Fig. 5). The crude product was purified by recrystallisation from ethanol to produce 0.53 g of 2-(4-nitrophenyl)benzimidazole (3d) (Ra = 98 percent). A similar procedure was applied for all other compounds. All the benzimidazole derivatives were fully characterised using the usual spectroscopic techniques.
Reference: [1] New Journal of Chemistry, 2018, vol. 42, # 22, p. 17931 - 17938
[2] Research on Chemical Intermediates, 2017, vol. 43, # 3, p. 1751 - 1766
[3] Applied Organometallic Chemistry, 2018, vol. 32, # 4,
[4] Journal of Organic Chemistry, 2013, vol. 78, # 22, p. 11184 - 11193
[5] Applied Organometallic Chemistry, 2018, vol. 32, # 10,
[6] Journal of Heterocyclic Chemistry, 2012, vol. 49, # 5, p. 1187 - 1195
[7] Magnetic Resonance in Chemistry, 2005, vol. 43, # 7, p. 551 - 556
[8] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 6, p. 1231 - 1240
  • 2
  • [ 2316-64-5 ]
  • [ 95-54-5 ]
  • [ 62871-28-7 ]
Reference: [1] Advanced Synthesis and Catalysis, 2018, vol. 360, # 18, p. 3563 - 3571
  • 3
  • [ 1761-61-1 ]
  • [ 62871-28-7 ]
Reference: [1] Recueil: Journal of the Royal Netherlands Chemical Society, 1983, vol. 102, # 2, p. 73 - 77
[2] Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 1982, vol. 21, # 9, p. 872 - 874
  • 4
  • [ 61131-72-4 ]
  • [ 95-54-5 ]
  • [ 62871-28-7 ]
Reference: [1] Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 1982, vol. 21, # 9, p. 872 - 874
  • 5
  • [ 51800-88-5 ]
  • [ 62871-28-7 ]
Reference: [1] Recueil: Journal of the Royal Netherlands Chemical Society, 1983, vol. 102, # 2, p. 73 - 77
  • 6
  • [ 61131-72-4 ]
  • [ 62871-28-7 ]
Reference: [1] Acta Chimica Hungarica, 1983, vol. 113, # 1, p. 87 - 91
  • 7
  • [ 29979-27-9 ]
  • [ 62871-28-7 ]
Reference: [1] Recueil: Journal of the Royal Netherlands Chemical Society, 1983, vol. 102, # 2, p. 73 - 77
  • 8
  • [ 87745-36-6 ]
  • [ 95-54-5 ]
  • [ 615-16-7 ]
  • [ 62871-28-7 ]
Reference: [1] Acta Chimica Hungarica, 1983, vol. 113, # 1, p. 87 - 91
  • 9
  • [ 95-54-5 ]
  • [ 1761-61-1 ]
  • [ 29979-27-9 ]
  • [ 62871-28-7 ]
Reference: [1] Recueil: Journal of the Royal Netherlands Chemical Society, 1983, vol. 102, # 2, p. 73 - 77
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 62871-28-7 ]

Aryls

Chemical Structure| 113270-73-8

[ 113270-73-8 ]

2-(4-Bromophenyl)-1H-imidazo[4,5-c]pyridine

Similarity: 0.79

Chemical Structure| 169205-78-1

[ 169205-78-1 ]

N4-(3-Bromophenyl)quinazoline-4,6-diamine

Similarity: 0.75

Chemical Structure| 29914-81-6

[ 29914-81-6 ]

1,3-Bis(1H-benzo[d]imidazol-2-yl)benzene

Similarity: 0.75

Chemical Structure| 760212-58-6

[ 760212-58-6 ]

1-(4-Bromophenyl)-2-phenyl-1H-benzo[d]imidazole

Similarity: 0.75

Chemical Structure| 52755-90-5

[ 52755-90-5 ]

2-(1H-Imidazol-2-yl)phenol

Similarity: 0.71

Bromides

Chemical Structure| 113270-73-8

[ 113270-73-8 ]

2-(4-Bromophenyl)-1H-imidazo[4,5-c]pyridine

Similarity: 0.79

Chemical Structure| 169205-78-1

[ 169205-78-1 ]

N4-(3-Bromophenyl)quinazoline-4,6-diamine

Similarity: 0.75

Chemical Structure| 760212-58-6

[ 760212-58-6 ]

1-(4-Bromophenyl)-2-phenyl-1H-benzo[d]imidazole

Similarity: 0.75

Chemical Structure| 1014613-64-9

[ 1014613-64-9 ]

4-Bromo-2-methyl-1H-pyrrolo[2,3-b]pyridine

Similarity: 0.71

Chemical Structure| 1044772-00-0

[ 1044772-00-0 ]

7-Bromo-1-methyl-2-phenyl-1H-imidazo[4,5-c]pyridine

Similarity: 0.70

Alcohols

Chemical Structure| 41292-66-4

[ 41292-66-4 ]

2-Methyl-1H-benzo[d]imidazol-5-ol

Similarity: 0.72

Chemical Structure| 52755-90-5

[ 52755-90-5 ]

2-(1H-Imidazol-2-yl)phenol

Similarity: 0.71

Chemical Structure| 74420-02-3

[ 74420-02-3 ]

4-Hydroxy-7-azaindole

Similarity: 0.68

Chemical Structure| 958649-15-5

[ 958649-15-5 ]

6-Bromo-4-hydroxyquinoline-3-carbonitrile

Similarity: 0.66

Chemical Structure| 933697-27-9

[ 933697-27-9 ]

2-(2-Aminoethyl)-1H-benzo[d]imidazol-4-ol

Similarity: 0.65

Related Parent Nucleus of
[ 62871-28-7 ]

Benzimidazoles

Chemical Structure| 29914-81-6

[ 29914-81-6 ]

1,3-Bis(1H-benzo[d]imidazol-2-yl)benzene

Similarity: 0.75

Chemical Structure| 760212-58-6

[ 760212-58-6 ]

1-(4-Bromophenyl)-2-phenyl-1H-benzo[d]imidazole

Similarity: 0.75

Chemical Structure| 41292-66-4

[ 41292-66-4 ]

2-Methyl-1H-benzo[d]imidazol-5-ol

Similarity: 0.72

Chemical Structure| 152628-02-9

[ 152628-02-9 ]

1,7'-Dimethyl-2'-propyl-1H,1'H-2,5'-bibenzo[d]imidazole

Similarity: 0.69

Chemical Structure| 40608-76-2

[ 40608-76-2 ]

2-Benzyl-5-methoxy-1H-benzo[d]imidazole

Similarity: 0.69